In a filing, Tarsus Pharmaceuticals Inc revealed its insider Farrow Jeffrey S unloaded Company’s shares for reported $0.29 million on Jun 18 ’24. In the deal valued at $27.47 per share,10,445 shares were sold. As a result of this transaction, Farrow Jeffrey S now holds 18,136 shares worth roughly $0.45 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Azamian Bobak R. sold 10,415 shares, generating $318,699 in total proceeds. Upon selling the shares at $30.60, the President/CEO and Board Chair now owns 26,456 shares.
Before that, Neervannan Seshadri sold 4,879 shares. Tarsus Pharmaceuticals Inc shares valued at $149,297 were divested by the Chief Operating Officer at a price of $30.60 per share. As a result of the transaction, Neervannan Seshadri now holds 64,767 shares, worth roughly $1.62 million.
Goldman initiated its Tarsus Pharmaceuticals Inc [TARS] rating to a Neutral in a research note published on November 20, 2023; the price target was $19. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in mid July with a ‘”an Outperform”‘ rating. Guggenheim began covering TARS with “Buy” recommendation on May 18, 2023. Barclays started covering the stock on August 01, 2022. It rated TARS as “an Overweight”.
Price Performance Review of TARS
On Friday, Tarsus Pharmaceuticals Inc [NASDAQ:TARS] saw its stock fall -11.44% to $25.01. Over the last five days, the stock has lost -7.51%. Tarsus Pharmaceuticals Inc shares have risen nearly 23.51% since the year began. Nevertheless, the stocks have risen 25.87% over the past one year. While a 52-week high of $42.50 was reached on 05/09/24, a 52-week low of $12.57 was recorded on 01/05/24. SMA at 50 days reached $30.62, while 200 days put it at $26.95. A total of 1.94 million shares were traded, compared to the trading of 0.65 million shares in the previous session.
Levels Of Support And Resistance For TARS Stock
The 24-hour chart illustrates a support level at 22.89, which if violated will result in even more drops to 20.76. On the upside, there is a resistance level at 27.98. A further resistance level may holdings at 30.94. The Relative Strength Index (RSI) on the 14-day chart is 34.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.09%. Stochastics%K at 30.57% indicates the stock is a holding.
The most recent change occurred on December 21, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.
